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Development and growth of the embryo and fetus are
complex processes inextricably linked to the ability of the
individual to reach childhood developmental milestones.
Insults or stimuli to which the embryo or fetus responds
during critical periods of intrauterine growth and development are now understood to alter the genetically dictated growth trajectory of the fetus and reprogram the
newborn’s long-term development and physiological path.
Basic experimental and clinical human studies demonstrate
that intrauterine growth restriction may result from in utero
insults such as uteroplacental insuﬃciency and/or hypoxia,
preeclampsia, preterm labor, and imbalanced nutrition. e
fetal responses to these insults manifest as a predisposition
to the development of the metabolic syndrome in postnatal
life. e “thriy phenotype hypothesis” has been proposed
to explain the mechanism by which in utero responsive
adaptations set in motion the series of developmental and
physiological adaptations to maximize the chances of in
utero survival [1–3]. While intrauterine growth restriction
resulting in low birth weight is recognized as a major risk
factor for noncommunicable diseases associated with the
metabolic syndrome, it is now apparent that both ends of
the birth weight spectrum are associated with having an
increased risk of adult-onset disease in later life [4, 5]. is
further highlights the necessity to understand both optimal
growth patterns that result in optimal birth weight and the
critically important role that they play in setting the stage for

health and the risk of disease in postnatal life. In this special
issue, we have gathered a number of excellent reviews, each
focussing upon diﬀerent facets of how an altered in utero
environment results in adaptations in fetal organ systems,
expanding our understanding of how perturbations at early
stages of development may have long-term consequences.
e placenta represents not only the junction between
the maternal and fetal circulatory systems, but also plays
an important role in regulating fetal nutritional supply. e
regulation of placental nutrient transport is multifactorial.
e review by S. Lager and T. L. Powell in this issue focuses
on factors regulating placental glucose, amino acid, and fatty
acid transporters. Particularly intriguing is the concept that
the placenta plays a major role in integrating maternal and
fetal signals to regulate overall nutrient supply, transport,
and thus fetal growth. Keeping with placental function, L.
Avagliano et al. discuss the mechanisms controlling placental
amino acid transport in the context of placental insuﬃciency
that results in I��R. eir review maintains a speci�c
emphasis on the human condition and the impact changes in
maternal amino acid concentrations have on placental transport and metabolism. e theme of the central role played by
the placenta in fetal growth and development is highlighted
in the article by D. T. Yates et al. which examines the topic
of placental insuﬃciency and reduced newborn muscle mass.
In their review, they probe the contribution of reduced
fetal oxygen tension during late gestation to modulating
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circulating catecholamines, as chronic hypercatecholaminemia reduces both fetal muscle development and growth.
ey highlight that developmental programming of skeletal
muscle adrenergic receptors may partially explain how the
metabolic and endocrine phenotype of IUGR oﬀspring leads
to diﬀerential nutrient utilization, linking skeletal muscle
development and later life disease risk. Adipose tissue has
also been identi�ed as being highly plastic and vulnerable to
changes in the in utero environment, leading to alterations
in postnatal metabolism. Various adipose depots appear to
be sensitive to the in utero environment, such that altered in
utero development may provide important linkages to aspects
of the metabolic syndrome in adult life. O. Sarr et al. discuss
how IUGR fetuses display increased lipogenic and adipogenic
capacity as oﬀspring and they review the roles factors such
as fetal hypoleptinemia, altered glucocorticoid signaling, and
chromatin remodeling may subsequently contribute to an
increased later life obesity risk.
An emerging theme in the �eld of developmental programming stems from observations that diﬀerent insults in
utero result in similar adverse postnatal phenotypes associated with the metabolic syndrome. e idea of a common
factor acting across the spectrum of in utero insults has been
suggested to explain this phenomenon. Indeed, oxidative
stress and activation of in�ammatory pathways have now
been proposed as key modulators of fetal growth [6, 7].
Oxidative stress in the fetal compartment can be generated
by several conditions, such as prenatal hypoxia, maternal
under- and overnutrition, and inappropriate exposure to
glucocorticoids. In their review, L. P. ompson and Y. AlHasan discuss possible origins of developmental reprogramming as a result of in utero oxidative stress. ey highlight
the important role that oxidant molecules have as signalling
factors in developmental programming and propose that
these eﬀects are mediated by epigenetic mechanisms. In
addition to oxidative stress pathways, in�ammatory complications that impact on proin�ammatory cytokines such as
IL-1, IL-6, and TNF-𝛼𝛼, as well as increased concentrations of
glucocorticoids also have major roles in the onset of altered
growth patterns in utero [8, 9]. R. E. Fisher et al. review the
oﬀspring’s susceptibility to a range of metabolic disorders
while focusing on the impact of activated in�ammatory
pathways and how changes in the neuroendocrine-immune
system are programmed.
e importance of the adrenal gland in fetal physiology
as a master regulator of fetal maturation and the initiation of parturition was �rst highlighted in the pioneering
work of Liggins and colleagues in the 1960 s and 70 s [10].
More recently, publications have reported that sustained
or repeated fetal stressors can activate the hypothalamicpituitary-adrenocortical (HPA) axis resulting in elevated cortisol production and early maturation of the adrenal cortex
contributing to fetal growth restriction. In their review,
D. A. Myers and C. A. Ducsay have explored the impact
of adrenocortical and adipose responses to high altitudeinduced, long-term hypoxia in the ovine fetus. ey show
that adaptive responses both at the level of the hypothalamus
and anterior pituitary as well as the adrenal cortex contribute
to altered adrenal gland function that may be invoked as a
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general adaptive response to intrauterine stress to promote
fetal survival. Given the importance of the HPA axis in
regulating fetal maturation, glucocorticoids are administered
to pregnant women at risk of preterm labour to promote fetal
lung surfactant maturation with lifesaving consequences. A
number of reviews in this issue examine the administration
of antenatal glucocorticoids from a developmental programming perspective. L. Bennet et al. report that the overall
impact of glucocorticoid administration on neurodevelopment is surprisingly unclear and, worryingly, that there is
evidence of postnatal eﬀects associated with impaired brain
development following prenatal exposure to glucocorticoids.
ey discuss the possibility that maternal glucocorticoids
may well be both protective and damaging, depending on the
precise timing before the preterm fetus and infant are exposed
to an hypoxia/ischemia insult. e authors conclude that,
as with so many aspects of prenatal care and neonatology,
timing is everything. Further examining the need for careful
use of glucocorticoids, J. Morrison et al. review the impact
of glucocorticoid use in the IUGR fetus and highlight the
important observation that antenatal glucocorticoids may not
have the same eﬀects in IUGR preterm fetuses as they do in
normally grown preterm fetuses.
Not only does this issue focus upon the direct impact
of complications arising from a suboptimal in utero environment, we also include reviews dealing with how existing maternal conditions may impact the lifelong health
trajectories of their oﬀspring. Epidemiological studies have
identi�ed that maternal asthma, during pregnancy, increases
the risk of a number of poor outcomes for the neonate
including growth restriction, lower birth weight, preterm
delivery, the need for neonatal resuscitation, and stillbirth.
V. L. Clion et al. discuss the evidence currently available to
support the hypothesis that children of mothers with asthma
may be at risk of lifelong health complications that include
diabetes and hypertension. An understudied area of public
health concern involves treatment of maternal conditions and
their later life implications for the developing oﬀspring. By
way of example, there is considerable uncertainty regarding
prescribing practices for pregnant women with severe and
persistent psychiatric disorders. S. Raha et al. discuss the
evidence for associating altered birth weight and maternal
antipsychotic use, highlighting the role of the placenta and
the possible impact of oxidative stress upon fetal growth.
is review sets the stage for further studies to better our
understanding of the eﬀects of these drugs on fetal growth
and consequences for the long-term health of the oﬀspring.
Recently, studies have also begun to highlight how an
adverse in utero environment may impact longevity. A key
component of longevity is telomere health and a number of
studies have now identi�ed that telomere development may
be impaired in association with altered fetal development,
and the etiology of the diseases associated with the metabolic
syndrome is beginning to be elucidated. In the review by S.
E. Hallows et al. the authors suggest that premature aging
or cellular senescence through increased oxidative stress and
DNA damage to the telomeric ends of chromosomes may
be initiators of disease processes. Finally, treatment at the
extremes of the U-shaped birth weight distribution is limited
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and prevention of the increased risk of developing metabolic
syndrome in later life is an area of active investigation. To
this end, N. Ma and D. B. Hardy explore a number of
the developmental processes contributing to the metabolic
syndrome and discuss possible intervention strategies.
is collection of review articles highlights the wide and
varied range of insults that the fetus may experience in
utero, to which the fetus can respond through a range of
adaptations which themselves may impact on the life course
of that individual. A better understanding of these wide
ranging insults and the similarities and diﬀerences in the fetal
responses and adaptation will not only allow the prediction
of the impact on health in adult life but also guide us in the
development of eﬀective intervention strategies.
Timothy R. H. Regnault
Mark J. Nijland
Helen Budge
Janna L. Morrison
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